Anand Mahindra has expressed strong support for Elon Musk's Neuralink Blindsight device, which recently received FDA approval. He believes that if the device meets its ambitious goals, it could surpass Musk's previous achievements with Tesla and SpaceX as his most significant contribution to humanity. The Blindsight device aims to restore vision to individuals who have lost their sight, even in cases of severe damage to the optic nerve or those who have been blind from birth, provided their visual cortex remains intact. Musk noted that the initial visual output would be low resolution, akin to early video game graphics, but future iterations could enhance vision beyond natural capabilities, including perception of infrared and ultraviolet light. Mahindra's endorsement highlights the potential transformative impact of this technology on the lives of many, echoing sentiments shared by other users on social media. As Neuralink prepares for human trials, the excitement surrounding the Blindsight device continues to grow.